Cargando…
Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue Culture
Accurate diagnosis and proper monitoring of cancer patients remain a key obstacle for successful cancer treatment and prevention. Therein comes the need for biomarker discovery, which is crucial to the current oncological and other clinical practices having the potential to impact the diagnosis and...
Autores principales: | Paul, Debasish, Kumar, Avinash, Gajbhiye, Akshada, Santra, Manas K., Srikanth, Rapole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613068/ https://www.ncbi.nlm.nih.gov/pubmed/23586059 http://dx.doi.org/10.1155/2013/783131 |
Ejemplares similares
-
Mass spectrometry and bioinformatics analysis data
por: Dutta, Mainak, et al.
Publicado: (2014) -
Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007) -
Protein Phosphatase 1 Regulatory Subunit SDS22 Inhibits Breast Cancer Cell Tumorigenesis by Functioning as a Negative Regulator of the AKT Signaling Pathway()()()
por: Paul, Debasish, et al.
Publicado: (2018) -
Mass spectrometry‐based tear proteomics for noninvasive biomarker discovery
por: Ponzini, Erika, et al.
Publicado: (2021) -
Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders
por: Venugopal, Abhilash, et al.
Publicado: (2009)